Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group

Journal of Clinical Oncology

Volumn 28, Issue 9, 2010, Pages 1573-1582

  Brekke, Helge R ^a   Ribeiro, Franclim R ^a   Kolberg, Matthias ^a   Ågesen, Trude H ^a   Lind, Guro E ^a   Eknæs, Mette ^a   Hall, Kirsten S ^a   Bjerkehagen, Bodil ^a   Van Den Berg, Eva ^a   Teixeira, Manuel R ^a   Mandahl, Nils ^a   Smeland, Sigbjørn ^a   Mertens, Fredrik ^a   Skotheim, Rolf I ^a   Lothe, Ragnhild A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 10; CHROMOSOME 16; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; NERVE SHEATH TUMOR; NEUROFIBROMA; PERIPHERAL NERVE; PREDICTION; PRIORITY JOURNAL; SURVIVAL; X CHROMOSOME; COPY NUMBER VARIATION; GENETICS; GENOME; MIDDLE AGED; MORTALITY; NERVOUS SYSTEM TUMOR; NEUROFIBROMATOSIS; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, X; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION; GENOME; HUMANS; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NERVOUS SYSTEM NEOPLASMS; NEUROFIBROMATOSIS 1; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77951904713     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.8989     Document Type: Article

References (57)

1. Weiss SW, Goldblum JR, Enzinger FM (eds): MPNST, in Enzinger and Weiss's Soft Tissue Tumors (ed 5). St Louis, MO, Elsevier Mosby, 2008, pp 903-941
2. Brooks DG: The neurofibromatoses: Hereditary predisposition to multiple peripheral nerve tumors. Neurosurg Clin N Am 15:145-155, 2004
3. Rasmussen SA, Friedman JM: NF1 gene and neurofibromatosis 1. Am J Epidemiol 151:33-40, 2000 (Pubitemid 30470392)
4. Ducatman BS, Scheithauer BW, Piepgras DG, et al: Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006-2021, 1986
5. Mertens F, Dal Cin P, De Wever I, et al: Cytogenetic characterization of peripheral nerve sheath tumours: A report of the CHAMP study group. J Pathol 190:31-38, 2000 (Pubitemid 30053350)
6. Mertens F, Rydholm A, Bauer HF, et al: Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer 61:793-798, 1995
7. Woodruff JM: Pathology of the major peripheral nerve sheath neoplasms. Monogr Pathol 38:129-161, 1996
8. Broders A: Squamous cell epithelioma of the lip: A study of 537 cases. JAMA 74:656-664, 1920
9. Kallioniemi OP, Kallioniemi A, Piper J, et al: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243, 1994 (Pubitemid 24238430)
10. Ribeiro FR, Diep CB, Jeronimo C, et al: Statistical dissection of genetic pathways involved in prostate carcinogenesis. Genes Chromosomes Cancer 45:154-163, 2006 (Pubitemid 43191022)
11. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, et al: Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 66:8984-8993, 2006 (Pubitemid 44521116)
12. Ribeiro FR, Henrique R, Hektoen M, et al: Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas. Mol Cancer 5:33, 2006
13. Jong K, Marchiori E, Meijer G, et al: Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 20:3636-3637, 2004 (Pubitemid 40136800)
14. Tabone-Eglinger S, Bahleda R, Côté JF, et al: Frequent EGFR positivity and overexpression in high-grade areas of human MPNSTs. Sarcoma 2008:849156, 2008
15. Watson MA, Perry A, Tihan T, et al: Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathol 14:297-303, 2004 (Pubitemid 39095992)
16. Storlazzi CT, Brekke HR, Mandahl N, et al: Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours. J Pathol 209:492-500, 2006 (Pubitemid 44194564)
17. Skotheim RI, Kallioniemi A, Bjerkhagen B, et al: Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome. J Clin Oncol 21:4586-4591, 2003 (Pubitemid 46594031)
18. Berner JM, Sorlie T, Mertens F, et al: Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: Studies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer 26:151-160, 1999 (Pubitemid 29416440)
19. Kourea HP, Orlow I, Scheithauer BW, et al: Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol 155:1855-1860, 1999
20. Nielsen GP, Stemmer-Rachamimov AO, Ino Y, et al: Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/ p16 inactivation. Am J Pathol 155:1879-1884, 1999
21. Ågesen TH, Flørenes VA, Molenaar WM, et al: Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. J Neuropathol Exp Neurol 64:74-81, 2005 (Pubitemid 40189481)
22. Lothe RA, Karhu R, Mandahl N, et al: Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res 56:4778-4781, 1996 (Pubitemid 26338084)
23. Schmidt H, Wurl P, Taubert H, et al: Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer 25:205-211, 1999 (Pubitemid 29266689)
24. Mechtersheimer G, Otano-Joos M, Ohl S, et al: Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer 25:362-369, 1999 (Pubitemid 29326143)
25. Schmidt H, Taubert H, Meye A, et al: Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Reckling-hausen's disease. Cancer Lett 155:181-190, 2000 (Pubitemid 30259133)
26. Koga T, Iwasaki H, Ishiguro M, et al: Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis. J Pathol 197:98-107, 2002 (Pubitemid 34450169)
27. Nakagawa Y, Yoshida A, Numoto K, et al: Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization. Oncol Rep 15:297-303, 2006
28. Ishiguro M, Iwasaki H, Takeshita M, et al: A cytogenetic analysis in two cases of malignant peripheral nerve sheath tumor showing hypodiploid karyotype. Oncol Rep 16:225-232, 2006
29. Bottillo I, Ahlquist T, Brekke H, et al: Germline and somatic NF1 mutations in sporadic and NF1- associated malignant peripheral nerve sheath tumours. J Pathol 217:693-701, 2009
30. Wong WW, Hirose T, Scheithauer BW, et al: Malignant peripheral nerve sheath tumor: Analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42:351-360, 1998 (Pubitemid 28502782)
31. Evans DG, Baser ME, McGaughran J, et al: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311-314, 2002 (Pubitemid 34526349)
32. Carli M, Ferrari A, Mattke A, et al: Pediatric malignant peripheral nerve sheath tumor: The Italian and German soft tissue sarcoma cooperative group. J Clin Oncol 23:8422-8430, 2005
33. Hagel C, Zils U, Peiper M, et al: Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors. J Neurooncol 82:187-192, 2007 (Pubitemid 46431864)
34. Hruban RH, Shiu MH, Senie RT, et al: Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 66:1253-1265, 1990 (Pubitemid 20310668)
35. Cashen DV, Parisien RC, Raskin K, et al: Survival data for patients with malignant schwannoma. Clin Orthop Relat Res 426:69-73, 2004 (Pubitemid 39167110)
36. Anghileri M, Miceli R, Fiore M, et al: Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution. Cancer 107:1065-1074, 2006 (Pubitemid 44291156)
37. Brekke HR, Kolberg M, Skotheim RI, et al: Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors. Neuro Oncol 11:514-528, 2009
38. Machner MP, Isberg RR: A bifunctional bacterial protein links GDI displacement to Rab1 activation. Science 318:974-977, 2007 (Pubitemid 350098993)
39. Froyen G, Van EH, Bauters M, et al: Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array- CGH: Important role for increased gene dosage of XLMR genes. Hum Mutat 28:1034-1042, 2007 (Pubitemid 47519397)
40. North KN, Riccardi V, Samango-Sprouse C, et al: Cognitive function and academic performance in neurofibromatosis: 1. Consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 48:1121-1127, 1997
41. Carter BZ, Mak DH, Shi Y, et al: Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML: Overcoming imatinib resistance. Cell Cycle 5:2223-2229, 2006 (Pubitemid 44546558)
42. Gold SJ, Ni YG, Dohlman HG, et al: Regulators of G-protein signaling (RGS) proteins: Region-specific expression of nine subtypes in rat brain. J Neurosci 17:8024-8037, 1997 (Pubitemid 27426238)
43. Lévy P, Vidaud D, Leroy K, et al: Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Mol Cancer 3:20, 2004
44. Kresse SH, Skarn M, Ohnstad HO, et al: DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH. Mol Cancer 7:48, 2008
45. McClendon AK, Osheroff N: DNA topoisomerase II, genotoxicity, and cancer. Mutat Res 623:83-97, 2007 (Pubitemid 47368578)
46. Würl P, Kappler M, Meye A, et al: Coexpression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma. Lancet 359:943-945, 2002 (Pubitemid 34246386)
47. Altieri DC: Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46-54, 2003
48. Bodempudi V, Yamoutpoor F, Pan W, et al: RAL overactivation in malignant peripheral nerve sheath tumors. Mol Cell Biol 29:3964-3974, 2009
49. Keizman D, Issakov J, Meller I, et al: Expression and significance of EGFR in malignant peripheral nerve sheath tumor. J Neurooncol 94:383-388, 2009
50. Holtkamp N, Malzer E, Zietsch J, et al: EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy. Neuro Oncol 10:946-957, 2008
51. Perrone F, Da Riva L, Orsenigo M, et al: PDGFRA, PDGFRB, EGFR, and downstream signalling activation in malignant peripheral nerve sheath tumor. Neuro Oncol [epub ahead of print on February 26, 2009]
52. Boutros R, Fanayan S, Shehata M, et al: The tumor protein D52 family: Many pieces, many puzzles. Biochem Biophys Res Commun 325:1115-1121, 2004 (Pubitemid 39539228)
53. Albino D, Scaruffi P, Moretti S, et al: Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory. Cancer 113:1412-1422, 2008
54. Ohtani N, Yamakoshi K, Takahashi A, et al: The p16INK4a-RB pathway: Molecular link between cellular senescence and tumor suppression. J Med Invest 51:146-153, 2004 (Pubitemid 39610908)
55. Perrone F, Tabano S, Colombo F, et al: P15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Clin Cancer Res 9:4132-4138, 2003 (Pubitemid 37204030)
56. Sabah M, Cummins R, Leader M, et al: Loss of p16 (INK4A) expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected malignant peripheral nerve sheath tumors. Appl Immunohistochem Mol Morphol 14:97-102, 2006
57. Bole-Feysot C, Goffin V, Edery M, et al: Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268, 1998 (Pubitemid 29117815)